Terms: = Gastric cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Clinical Outcome
260 results:
1. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
[TBL] [Abstract] [Full Text] [Related]
2. clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.
Liang K; Feliciano JL; Marrone KA; Murray JC; Hann CL; Anagnostou V; Tackett SA; Shin EJ; Hales RK; Voong KR; Battafarano RJ; Yang SC; Broderick SR; Ha JS; Forde PM; Brahmer JR; Lam VK
ESMO Open; 2024 Jan; 9(1):102199. PubMed ID: 38071928
[TBL] [Abstract] [Full Text] [Related]
3. Targeting PRSS23 with tipranavir induces gastric cancer stem cell apoptosis and inhibits growth of gastric cancer via the MKK3/p38 MAPK-IL24 pathway.
Xiong JX; Li YT; Tan XY; Chen T; Liu BH; Fu L
Acta Pharmacol Sin; 2024 Feb; 45(2):405-421. PubMed ID: 37814123
[TBL] [Abstract] [Full Text] [Related]
4. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
[TBL] [Abstract] [Full Text] [Related]
5. Comparing effectiveness and safety of paclitaxel plus raltitrexed
Zhao X; Chen Z; Zhang X; Zhu X; Zhang W; Qiu L; Wang C; Huang M; Zhang Z; Li W; Yang L; Guo W
Cancer Biol Med; 2023 Aug; 20(9):682-8. PubMed ID: 37653589
[TBL] [Abstract] [Full Text] [Related]
6. PYloroplasty versus No Intervention in gastric REmnant REconstruction after Oesophagectomy: study protocol for the PYNI-GAREREO phase III randomized controlled trial.
Okada N; Kinoshita Y; Nishihara S; Kurotaki T; Sato A; Kimura K; Kushiya H; Umemoto K; Furukawa S; Yamabuki T; Takada M; Kato K; Ambo Y; Nakamura F
Trials; 2023 Jun; 24(1):412. PubMed ID: 37337238
[TBL] [Abstract] [Full Text] [Related]
7. A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
Gravis G; Marino P; Olive D; Penault-LLorca F; Delord JP; Simon C; Lamrani-Ghaouti A; Sabatier R; Ciccolini J; Boher JM
BMC Cancer; 2023 May; 23(1):393. PubMed ID: 37131154
[TBL] [Abstract] [Full Text] [Related]
8. Quality performance indicator compliance for the treatment of gastric adenocarcinoma.
Wang Y; Kulasegaran S; Srinivasa S; Koea J; MacCormick A
ANZ J Surg; 2023 May; 93(5):1294-1299. PubMed ID: 36825561
[TBL] [Abstract] [Full Text] [Related]
9. The correlation of serum sirt6 with clinical outcome and prognosis in patients with gastric cancer.
Li D; Cao C
Medicine (Baltimore); 2022 Nov; 101(47):e31568. PubMed ID: 36451443
[TBL] [Abstract] [Full Text] [Related]
10. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract] [Full Text] [Related]
11. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
[No Abstract] [Full Text] [Related]
12. Identification of specific role of SNX family in gastric cancer prognosis evaluation.
Hu B; Yin G; Sun X
Sci Rep; 2022 Jun; 12(1):10231. PubMed ID: 35715463
[TBL] [Abstract] [Full Text] [Related]
13. Role of Collagen Gel Droplet-Embedded Culture-Drug Sensitivity Testing (CD-DST) for Assessing the Sensitivity of gastric cancer to Chemotherapy Drugs Combined with Other cancer Therapeutic Drugs.
Makino H; Nomura S; Kogo H; Wada N; Hayashi M; Yoshida H
J Nippon Med Sch; 2022 Aug; 89(4):412-421. PubMed ID: 35400719
[TBL] [Abstract] [Full Text] [Related]
14. Low clarithromycin resistance in virulent Helicobacter pylori from dyspeptic patients at a tertiary care centre in Odisha.
Hallur V; Panigrahi M; Sable M; Ghosh M; Mohanty S; Purkait S; Praharaj A
Indian J Med Microbiol; 2022; 40(2):211-216. PubMed ID: 35346525
[TBL] [Abstract] [Full Text] [Related]
15. clinical outcome of the delineation-without-negative-biopsy strategy in magnifying image-enhanced endoscopy for identifying the extent of differentiated-type early gastric cancer.
Kitagawa Y; Ishigaki A; Nishii R; Sugita O; Hara T; Suzuki T
Surg Endosc; 2022 Sep; 36(9):6576-6585. PubMed ID: 35233660
[TBL] [Abstract] [Full Text] [Related]
16. clinical outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Fujii H; Iwaki M; Hayashi H; Toyoda H; Oeda S; Hyogo H; Kawanaka M; Morishita A; Munekage K; Kawata K; Yamamura S; Sawada K; Maeshiro T; Tobita H; Yoshida Y; Naito M; Araki A; Arakaki S; Kawaguchi T; Noritake H; Ono M; Masaki T; Yasuda S; Tomita E; Yoneda M; Kawada N; Tokushige A; Kamada Y; Takahashi H; Ueda S; Aishima S; Sumida Y; Nakajima A; Okanoue T;
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):370-379. PubMed ID: 35051649
[TBL] [Abstract] [Full Text] [Related]
17. clinical outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of gastric cancer.
Sindayigaya R; Dogan C; Demtröder CR; Fischer B; Karam E; Buggisch JR; Tempfer CB; Lecomte T; Ouaissi M; Giger-Pabst U
Ann Surg Oncol; 2022 Jan; 29(1):112-123. PubMed ID: 34611790
[TBL] [Abstract] [Full Text] [Related]
18. Effects of MSCT enhanced scan image diagnosis on clinical outcome of patients after radical gastrectomy and its influence on misdiagnosis rate.
Yang D; Zhou Y; Peng Z; Ou N
J BUON; 2021; 26(4):1479-1484. PubMed ID: 34565007
[TBL] [Abstract] [Full Text] [Related]
19. Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors.
Altieri B; Barrea L; Modica R; Bottiglieri F; de Cicco F; Muscogiuri G; Circelli L; Savarese G; Di Somma C; Savastano S; Colao A; Faggiano A
Endocrine; 2022 Feb; 75(2):623-634. PubMed ID: 34533768
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis.
Lv Y; Xu M; Sun Y; Liu Y; Zhao L; Liu X; Li Z; Shi G; Jia J; Bi L; Ma N; Zhang X; Qi C
Medicine (Baltimore); 2021 Aug; 100(33):e26850. PubMed ID: 34414935
[TBL] [Abstract] [Full Text] [Related]
[Next]
